Manchester-based molecular diagnostics firm Yourgene Health plc announced that Yourgene Genomic Services (YG) has been awarded a contract for the provision of laboratory capacity to support the Winter Surge Covid-19 testing by the Department of Health & Social Care (DHSC), running until March 31, 2022.

“The ‘Mini Tender Winter Surge Capacity (C47365)’ contract is the third DHSC contract awarded to the group this year under the Public Health England National Microbiology Framework Agreement,” said Yourgene.

“The previous two awards include the Covid-19 PCR surge testing announced on 19 August 2021 and the recent UKHSA sequencing contract announced on 14 December 2021.”

Yourgene CEO Lyn Rees said: “This is another strong endorsement of our progress and we are pleased to be able to support the nation’s Covid testing effort.

“Actual value for this contract will depend on the services purchased, with no committed spend at this moment in time, but we look forward to updating shareholders on the progress over time.”